54
Views
1
CrossRef citations to date
0
Altmetric
Research Article

Neuromodulation mediated by the tachykinin NK3-receptor agonist [MePhe7]-neurokinin B in the isolated perfused lung of nonsensitized nonchallenged and ovalbumin-sensitized and -challenged guinea pig

, , &
Pages 233-249 | Received 03 Oct 2011, Accepted 29 Feb 2012, Published online: 26 Apr 2012

REFERENCES

  • van der Velden VHJ, Hulsmann AR: Autonomic innervation of human airways: structure, function, and pathophysiology in asthma. Neuroimmunomodulation. 1999;6:145–159.
  • Joos GF, Germonpre PR, Pauwels RA: Neural mechanisms in asthma. Clin Exp Allergy. 2000;30:60–65.
  • Lou Y-P: Regulation of neuropeptide release from pulmonary capsaicin-sensitive afferents in relation to bronchoconstriction. Acta Physiol Scand. 1993;612(Supp):1–88.
  • Undem BJ, Myers AC, Barthlow H, Weinreich D: Vagal innervation of guinea pig bronchial smooth muscle. J Appl Physiol. 1990;69:1336–1346.
  • Raemdonck K, de Alba J, Birrell MA, Grace M, Maher SA, Irvin CG, Fozard JR, O'Byrne PM, Belvisi MG: A role for sensory nerves in the late asthmatic response. Thorax. 2012;67:19–25.
  • Belvisi MG, Barnes PJ, Rogers DF: Neurogenic inflammation in the airways: characterization of electrical parameters for vagus nerve stimulation in the guinea pig. J Neuro Methods. 1990;32:159–167.
  • Baluk P, Bertrand C, Geppetti P, McDonald DM, Nadel JA: NK1 receptors mediate leukocyte adhesion in neurogenic inflammation in the rat trachea. Am J Physiol. 1995;268: L263–L269.
  • Joos GF, De Swert KO, Pauwels RA: Airway inflammation and tachykinins: prospects for the development of tachykinin receptor antagonists. Eur Respir J. 2001;429:239–250.
  • Lundberg JM, Martling C-R, Saria A: Substance P and capsaicin-induced contractions of human bronchi. Acta Physiol Scand. 1983;119:49–53.
  • Lundberg JM, Saria A, Brodin E, Rosell S, Folkers K: A substance P antagonist inhibits vagally induced increases in vascular permeability and bronchial smooth muscle contraction in the guinea pig. Proc Natl Acad Sci U S A. 1983;80:1120–1124.
  • Chitano P, Di Blasi P, Lucchini RE. Calabro F, Saetta M, Maestrelli P, Fabbri LM, Mapp CE: The effects of toluene diisocyanate and of capsaicin on human bronchial smooth muscle in vitro. Eur J Pharmacol. 1994;270:167–173.
  • Solway J, Leff AR: Sensory neuropeptides and airway function. J Appl Physiol. 1991;71:2077–2087.
  • Hua XY, Theodorsson-Norheim E, Brodin E, Lundberg JM, Hokfelt T: Multiple tachykinins (neurokinin A, neurokinin K and substance P) in capsaicin-sensitive sensory neurons in the guinea-pig. Regul Pept. 1985;13:1–19.
  • Lundberg JM, Hokfeldt T, Martling C-R, Saria A, Cuello C: Substance P-immunoreactive sensory nerves in the lower respiratory tract of various mammals including man. Cell Tissue Res. 1984;235:251–261.
  • Tomaki M, Ichinose M, Miura M, Hirayama Y, Yamauchi H, Nakajima N, Shirato K: Elevated substance P content in induced sputum from patients with asthma and patients with chronic bronchitis. Am J Respir Crit Care Med. 1995;151:613–617.
  • Nieber K, Baumgarten CR, Rathsack R, Furkert J, Oehme P, Kunkel G: Substance P and beta-endorphin-like immunoreactivity in lavage fluid of subjects with and without allergic asthma. J Allergy Clin Immunol. 1992;90:646–652.
  • Heaney LG, Cross LJM, McGarvey LPA, Buchanan KD, Ennis M, Shaw C: Neurokinin A is the predominant tachykinin in human bronchoalveolar lavage fluid in normal and asthmatic subjects. Thorax. 1998;53:357–362.
  • Bai TR, Zhou D, Weir T, Walker B, Hegele R, Hayashi S, McKay K, Bondy GP, Fong T: Substance P (NK1)- and neurokinin A (NK2)-receptor gene expression in inflammatory airway disease. Am J Physiol. 1995;269:L309–L317.
  • Baluk P, McDonald DM: Proinflammatory peptides in sensory nerves of the airways. In: Said SS, ed. Proinflammatory and Anti-inflammatory Peptides. New York: Marcel Decker; 1998;112:45–87.
  • Myers A, Undem B, Kummer W: Anatomical and electrophysiological comparison of the sensory innervation of bronchial and tracheal parasympathetic ganglion neurons. J Auton Nerv Syst. 1996;61:162–168.
  • Myers AC, Goldie RG, Hay DWP: A novel role for tachykinin neurokinin-3 receptors in regulation of human bronchial ganglia neurons. Am J Respir Crit Care Med. 2005;171:212–216.
  • Tanaka DT, Grunstein MM: Effect of substance P on neurally mediated contraction of rabbit airway smooth muscle. J Appl Physiol. 1986;60:458–463.
  • Watson N, Maclagan J, Barnes PJ: Endogenous tachykinins facilitate transmission through parasympathetic ganglia in guinea-pig trachea. Br J Pharmacol. 1993;109:751–759.
  • Lou Y-P, Lee L-Y, Satoh H, Lundberg JM: Postjunctional inhibitory effect of the NK2 receptor antagonist, SR 48968, on sensory NANC bronchoconstriction in the guinea-pig. Br J Pharmacol. 1993;109:765–773.
  • Savoie C, Tousignant C, Rodger IW, Chan C-C: Involvement of NK1 and NK2 receptors in pulmonary responses elicited by non-adrenergic, non-cholinergic vagal stimulation in guinea-pigs. J Pharm Pharmacol. 1995;47:914–920.
  • Tocker JE, Gertner SB, Welton AF, Selig WM: Vagal stimulation augments pulmonary anaphylaxis in the guinea pig lung. Am J Respir Crit Care Med. 1995;151:461–469.
  • Colasurdo GN, Loader JE, Graves JP, Larsen GL: SP-induced contraction of airway smooth muscle in normal and allergen-sensitized rabbits: mechanism of action. J Appl Physiol. 1995;78:428–432.
  • Saria A, Martling C-R, Yan Z, Theodorsson-Norheim E, Gamse R, Lundberg JM: Release of multiple tachykinins from capsaicin-sensitive sensory nerves in the lung by bradykinin, histamine, dimethylphenyl piperazinium, and vagal nerve stimulation. Am Rev Respir Dis. 1988;137:1330–1335.
  • Tournoy KG, De Swert KO, Leclere PG, Lefebvre RA, Pauwels RA, Joos GF: Modulatory role of the tachykinin NK1 receptor in cholinergic contraction of mouse trachea. Eur Respir J. 2003;21:3–10.
  • Black JL, Johnson PRA, Alouan L Amour CI: Neurokinin A with K+ channel blockade potentiates contraction to electrical stimulation in human bronchus. Eur J Pharmacol. 1990;180:311–317.
  • Venugopalan CS, Holmes EP, Fucci V, Guthrie AJ: Stimulation frequency-dependent nonadrenergic noncholinergic airway responses of the guinea pig. J Appl Physiol. 1991;70:1006–1010.
  • Corboz MR, Rivelli MA, Eckel SP: Bronchoconstrictor effect of the tachykinin NK3-receptor agonists [MePhe7]-neurokinin B and senktide in the isolated guinea pig lung. Exp Lung Res. 2010;36:509–521.
  • Saria A, Dalsgaard CJ, Lundberg JM: Evidence for substance P-immunoreactive spinal afferents that mediate bronchoconstriction. Acta Physiol Scand. 1985;125:407–414.
  • Mazzone SB, Canning BJ: An in vivo guinea pig preparation for studying the autonomic regulation of airway smooth muscle tone. Auton Neurosc Basic Clin. 2002;99:91–101.
  • Underwood S, Foster M, Raeburn D, Bottoms S, Karlsson J-A: Time-course of antigen-induced airway inflammation in the guinea-pig and its relationship to airway hyperresponsiveness. Eur Respir J. 1995;8:2104–2113.
  • Billah MM, Cooper N, Minnicozzi M, Warneck J, Wang P, Hey JA, Kreutner W, Rizzo CA, Smith SR, Young S, Chapman RW, Dyke H, Shih N-Y, Piwinski JJ, Cuss FM, Montana J, Ganguly AK, Egan RW: Pharmacology of N-(3,5-dichloro-1-oxido-4-pyridinyl)-8-methoxy-2-(trifluoromethyl)-5-quinoline carboxamide (SCH 351591), a novel, orally active phosphodiesterase 4 inhibitor. J Pharmacol Exp Ther. 2002;302:127–137.
  • Savoie C, Plant M, Zwikker M, van Staden CJ, Boulet L, Chan CC, Rodger IW, Pon DJ: Effect of dexamethasone on antigen-induced high molecular weight glycoconjugate secretion in allergic guinea pigs. Am J Respir Cell Mol Biol. 1995;13: 133–143.
  • Agusti C, Takeyama K, Cardell LO, Ueki I, Lausier J, Lou Y-P, Nadel JA: Goblet cell degranulation after antigen challenge in sensitized guinea pigs. Am J Respir Crit Care Med. 1998;158:1253–1258.
  • Li Y, Martin LD, Minnicozzi M, Greenfeder S, Fine J, Pettersen CA, Chorley B, Adler KB: Enhanced expression of mucin genes in a guinea pig model of allergic asthma. Am J Respir Cell Mol Biol. 2001;25:644–651.
  • Spond J, Case N, Chapman RW, Crawley Y, Egan RW, Fine J, Hey JA, Kreutner W, Kung T, Wang P, Minnicozzi M: Inhibition of experimental acute pulmonary inflammation by pirfenidone. Pulm Pharmacol Ther. 2003;16:207–214.
  • Daoui S, Cui YY, Lagente V, Emonds-Alt X, Advenier C: A tachykinin NK3 receptor antagonist, SR 142801 (osanetant), prevents substance P-induced bronchial hyperreactivity in guinea-pigs. Pulm Pharmacol Ther. 1997;10:261–270.
  • Daoui S, Cognon C, Naline E, Emonds-Alt X: Involvement of tachykinin NK3 receptor in citric-acid-induced cough and bronchial responses in guinea-pigs. Am J Respir Crit Care Med. 1998;158:42–48.
  • Daoui S, Naline E, Lagente V, Emonds-Alt X, Advenier C: Neurokinin B- and specific tachykinin NK3 receptor agonists-induced airway hyperresponsiveness in the guinea-pig. Br J Pharmacol. 2000;130:49–56.
  • Hay DWP, Giardina GAM, Griswold DE, Underwood DC, Kotzer CJ, Bush B, Potts W, Sandhu P, Lundberg D, Foley JJ, Schmidt DB, Martin LD, Kilian D, Legos JJ, Barone FC, Luttmann MA, Grugni M, Raveglia LF, Sarau HM: Nonpeptide tachykinin receptor antagonists. III. SB 235375, a low central nervous system-penetrant, potent and selective neurokinin-3 receptor antagonist, inhibits citric acid-induced cough and airways hyper-reactivity in guinea pigs. J Pharmacol Exp Ther. 2002;300:314–323.
  • Mukaiyama O, Morimoto K, Nosaka E, Takahashi S, Yamashita M: Involvement of enhanced neurokinin NK3 receptor expression in the severe asthma guinea pig model. Eur J Pharmacol. 2004;498:287–294.
  • Corboz MR, Rivelli MA, Egan RW Tulshian D., Matasi J, Fawzi AB, Benbow L, Smith-Torhan A, Zhang H, Hey JA: Nociceptin inhibits capsaicin-induced bronchoconstriction in isolated guinea pig lung. Eur J Pharmacol. 2000;402:171–179.
  • Corboz MR, Fernandez X, Rizzo CA, Tozzi S, Monahan ME, Hey JA: Increased blocking activity of combined tachykinin NK1- and NK2-receptor antagonists on tachykinergic bronchomotor responses in the guinea-pig. Auton Autac Pharmacol. 2003;23:79–93.
  • Ellis JL, Undem BJ, Kays JS, Ghanekar SV, Barthlow HG, Buckner CK: Pharmacological examination of receptors mediating contractile responses to tachykinins in airways isolated from human, guinea pig and hamster. J Pharmacol Exp Ther. 1993;267:95–101.
  • Tallarida RJ: Pharmacologic methods for identification of receptors. Life Sci. 1988;43:2169–2176.
  • DeJongste JC, Mons H, Bonta IL, Kerrebijn KF: Nonneuronal components in the response of fresh human airways to electrical field stimulation. J Appl Physiol. 1987;63:1558–1566.
  • Hall AK, Barnes PJ, Meldrum LA, Maclagan J: Facilitation by tachykinins of neurotransmission in guinea-pig pulmonary parasympathetic nerves. Br J Pharmacol. 1989;97: 274–280.
  • Costello RW, Fryer AD, Belmonte KE, Jacoby DB: Effects of tachykinin NK1 receptor antagonists on vagal hyperreactivity and neuronal M2 muscarinic receptor function in antigen challenged guinea-pigs. Br J Pharmacol. 1998;124:267–276.
  • Belvisi MG, Patacchini R, Barnes PJ, Maggi CA: Facilitatory effects of selective agonists for tachykinin receptors on cholinergic neurotransmission: evidence for species differences. Br J Pharmacol. 1994;111:103–110.
  • Joos GF, Germonpre PR, Pauwels RA: Role of tachykinin in asthma. Allergy. 2000;55:321–337.
  • Frossard N, Barnes PJ: Effect of tachykinins in small human airways. Neuropeptides. 1991;19:157–161.
  • Hulsmann AR, de Jongste JC: Studies of human airways in vitro: a review of the methodology. J Pharmacol Toxicol Methods. 1993;30:117–132.
  • Myers AC, Undem BJ: Electrophysiological effects of tachykinins and capsaicin on guinea-pig bronchial parasympathetic ganglion neurones. J Physiol. 1993;470:665–679.
  • Lundberg JM, Saria A: Polypeptide-containing neurons in airway smooth muscle. Ann Rev Physiol. 1987;49:557–572.
  • Corboz MR, Rivelli MA, Ramos SI, Rizzo CA, Hey JA: Tachykinin NK1 receptor-mediated vasorelaxation in human pulmonary arteries. Eur J Pharmacol. 1998;350:R1–R3.
  • Piedimonte G, Hoffman JIE, Husseini WK, Snider RM, Desai MC, Nadel JA: NK1 receptors mediate neurogenic inflammatory increase in blood flow in rat airways. J Appl Physiol. 1993;74:2462–2468.
  • Robineau P, Lonchampt M, Kucharczyk N, Krause JE, Regoli D, Fauchere J-L, Prost J-F, Canet E: In vitro and in vivo pharmacology of S 16474, a novel dual tachykinin NK1 and NK2 receptor antagonist. Eur. J. Pharmacol. 1995;294: 677–684.
  • Lotvall JO, Lemen RJ, Hui KH, Barnes PJ, Chung KF: Airflow obstruction after substance P aerosol: contribution of airway and pulmonary edema. J Appl Physiol. 1990;69:1473–1478.
  • Delay-Goyet P, Lundberg JM: Cigarette smoke-induced airway oedema is blocked by the NK1 antagonist, CP-96,345. Eur J Pharmacol. 1991;203:157–158.
  • Tanaka DT, Grunstein MM: Mechanisms of substance P-induced contraction of rabbit airway smooth muscle. J Appl Physiol. 1984;57:1551–1557.
  • Joos GF, Pauwels RA, Van Der Straeten ME: The mechanism of tachykinin-induced bronchoconstriction in the rat. Am Rev Respir Dis. 1988;137:1038–1044.
  • Joos GF, Pauwels RA, Van Der Straeten ME: The effect of nedocromil sodium on the bronchoconstrictor effect of neurokinin A in asthmatics. J Allergy Clin Immunol. 1989;83:663–668.
  • Crimi N, Palermo F, Oliveri R: Effect of nedocromil on bronchospasm induced by inhalation of substance P in asthmatic subjects. Clin Allergy. 1988;18:375–382.
  • Joos GF, Pauwels RA, Van Der Straeten ME: The effect of oxitropium bromide on neurokinin A-induced bronchoconstriction in asthmatics. Pulm Pharmacol. 1988;1:41–45.
  • Crimi N, Palermo F, Oliveri R: Influence of antihistamine (astemizole) and anticholinergic drugs (ipratropium bromide) on bronchoconstriction induced by substance P. Ann Allergy. 1990;65:115–120.
  • Joos GF, Germonpre PR, Kips JC, Peleman RA, Pauwels RA: Sensory neuropeptides and the human lower airways: present state and future directions. Eur Respir J. 1994;7:1161–1171.
  • Pinto FM, Saulnier J-P, Faisy C, Naline E, Molimard M, Prieto L, Martin JD, Emonds-Alt X, Advenier C, Candenas ML: SR 142801, a tachykinin NK3 receptor antagonist, prevents β2-adrenoceptor agonist-induced hyperresponsiveness to neurokinin A in guinea-pig isolated trachea. Life Sci. 2002;72:307–320.
  • Fisher A, Philippin B, Saria A, McGregor G, Kummer W: Neuronal plasticity in sensitized and challenged guinea pigs: neuropeptides and neuropeptide gene expression. Am J Respir Crit Care Med. 1994;149:A890.
  • Boichot E, Germain N, Lagente V, Advenier C: Prevention by the tachykinin NK2 receptor antagonist, SR 48968, of antigen-induced airway hyperresponsiveness in sensitized guinea-pigs. Br J Pharmacol. 1995;114:259–261.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.